NANOVIRICIDES, INC. Amortization
NANOVIRICIDES, INC. (NNVC) reported Amortization of $2.07 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:AdjustmentForAmortization · last filed 2022-05-16
- NANOVIRICIDES, INC. amortization for the quarter ending 2022-03-31 was $2.07K, a 0.00% change year-over-year.
- NANOVIRICIDES, INC. amortization for the quarter ending 2021-12-31 was $2.07K, a 0.00% change year-over-year.
- NANOVIRICIDES, INC. amortization for the quarter ending 2021-09-30 was $2.07K, a 0.00% change year-over-year.
- NANOVIRICIDES, INC. amortization for the quarter ending 2021-03-31 was $2.07K, a 0.10% decline year-over-year.
- NANOVIRICIDES, INC. amortization for fiscal 2018 was $8.27K, a 0.00% change from fiscal 2017.
- NANOVIRICIDES, INC. amortization for fiscal 2017 was $8.27K, a 0.01% decline from fiscal 2016.
- NANOVIRICIDES, INC. amortization for fiscal 2016 was $8.27K, a 2.95% decline from fiscal 2015.
- NANOVIRICIDES, INC. amortization for fiscal 2015 was $8.52K, a 2.89% decline from fiscal 2014.
| Period end | Amortization 3 month | Amortization 3 month as first filed | Amortization 6 month | Amortization 9 month | Amortization 12 month | Amortization 86 month | Amortization 89 month | Amortization 92 month | Amortization 95 month | Amortization 99 month | Amortization 101 month | Amortization 104 month | Amortization 107 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-31 | $2.07K 10-Q · filed 2022-05-16 | $4.13K derived: sum of 2 quarters · filed 2022-05-16 | $6.20K 10-Q · filed 2022-05-16 | ||||||||||
| 2021-12-31 | $2.07K 10-Q · filed 2022-02-14 | $4.13K 10-Q · filed 2022-02-14 | |||||||||||
| 2021-09-30 | $2.07K 10-Q · filed 2021-11-15 | ||||||||||||
| 2021-03-31 | $2.07K 10-Q · filed 2022-05-16 | $4.13K derived: sum of 2 quarters · filed 2022-05-16 | $6.20K 10-Q · filed 2022-05-16 | ||||||||||
| 2020-12-31 | $2.07K 10-Q · filed 2022-02-14 | $4.13K 10-Q · filed 2022-02-14 | |||||||||||
| 2020-09-30 | $2.07K 10-Q · filed 2021-11-15 | ||||||||||||
| 2020-03-31 | $2.07K 10-Q · filed 2021-05-14 | $4.14K derived: sum of 2 quarters · filed 2021-05-14 | $6.20K 10-Q · filed 2021-05-14 | ||||||||||
| 2019-12-31 | $2.07K 10-Q · filed 2021-02-16 | $2.07K 10-Q · filed 2020-02-14 | $4.13K 10-Q · filed 2021-02-16 | ||||||||||
| 2019-09-30 | $2.07K 10-Q · filed 2020-11-16 | ||||||||||||
| 2019-03-31 | $2.07K 10-Q · filed 2020-06-22 | $4.13K derived: sum of 2 quarters · filed 2020-06-22 | $6.20K 10-Q · filed 2020-06-22 | $8.27K derived: sum of 4 quarters · filed 2020-06-22 | |||||||||
| 2018-12-31 | $2.07K 10-Q · filed 2020-02-14 | $4.14K 10-Q · filed 2020-02-14 | $6.20K derived: sum of 3 quarters · filed 2020-02-14 | $8.27K derived: sum of 4 quarters · filed 2020-02-14 | |||||||||
| 2018-09-30 | $2.07K 10-Q · filed 2019-11-15 | $4.14K derived: sum of 2 quarters · filed 2019-11-15 | $6.20K derived: sum of 3 quarters · filed 2019-11-15 | $8.27K derived: sum of 4 quarters · filed 2019-11-15 | |||||||||
| 2018-06-30 | $2.07K derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-12 | $4.13K derived: sum of 2 quarters · filed 2019-05-15 | $6.20K derived: sum of 3 quarters · filed 2019-05-15 | $8.27K 10-K · filed 2018-10-12 | |||||||||
| 2018-03-31 | $2.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-15 | $4.13K derived: sum of 2 quarters · filed 2019-05-15 | $6.20K 10-Q · filed 2019-05-15 | $8.27K derived: sum of 4 quarters · filed 2019-05-15 | |||||||||
| 2017-12-31 | $2.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-14 | $4.13K 10-Q · filed 2019-02-14 | $6.20K derived: sum of 3 quarters · filed 2019-02-14 | $8.27K derived: sum of 4 quarters · filed 2019-02-14 | |||||||||
| 2017-09-30 | $2.07K 10-Q · filed 2018-11-14 | $4.14K derived: sum of 2 quarters · filed 2018-11-14 | $6.20K derived: sum of 3 quarters · filed 2018-11-14 | $8.27K derived: sum of 4 quarters · filed 2018-11-14 | |||||||||
| 2017-06-30 | $2.07K derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-12 | $4.13K derived: sum of 2 quarters · filed 2018-10-12 | $6.20K derived: sum of 3 quarters · filed 2018-10-12 | $8.27K 10-K · filed 2018-10-12 | |||||||||
| 2017-03-31 | $2.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-21 | $4.13K derived: sum of 2 quarters · filed 2018-05-21 | $6.20K 10-Q · filed 2018-05-21 | $8.27K derived: sum of 4 quarters · filed 2018-10-12 | |||||||||
| 2016-12-31 | $2.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-20 | $4.13K 10-Q · filed 2018-02-20 | $6.20K derived: sum of 3 quarters · filed 2018-10-12 | $8.27K derived: sum of 4 quarters · filed 2018-10-12 | |||||||||
| 2016-09-30 | $2.07K 10-Q · filed 2017-11-14 | $4.13K derived: sum of 2 quarters · filed 2018-10-12 | $6.20K derived: sum of 3 quarters · filed 2018-10-12 | $8.27K derived: sum of 4 quarters · filed 2018-10-12 | |||||||||
| 2016-06-30 | $2.07K derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-12 | $4.13K derived: sum of 2 quarters · filed 2018-10-12 | $6.20K derived: sum of 3 quarters · filed 2018-10-12 | $8.27K 10-K · filed 2018-10-12 | |||||||||
| 2016-03-31 | $2.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-15 | $4.13K derived: sum of 2 quarters · filed 2017-05-15 | $6.20K 10-Q · filed 2017-05-15 | $8.27K derived: sum of 4 quarters · filed 2017-09-28 | |||||||||
| 2015-12-31 | $2.07K 10-Q · filed 2016-02-09 | $4.13K 10-Q · filed 2017-02-14 | $6.20K derived: sum of 3 quarters · filed 2017-09-28 | $8.27K derived: sum of 4 quarters · filed 2017-09-28 | |||||||||
| 2015-09-30 | $2.07K 10-Q · filed 2016-11-14 | $4.13K derived: sum of 2 quarters · filed 2017-09-28 | $6.20K derived: sum of 3 quarters · filed 2017-09-28 | $8.39K derived: sum of 4 quarters · filed 2017-09-28 | |||||||||
| 2015-06-30 | $2.07K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-28 | $4.13K derived: sum of 2 quarters · filed 2017-09-28 | $6.33K derived: sum of 3 quarters · filed 2017-09-28 | $8.52K 10-K · filed 2017-09-28 | |||||||||
| 2015-03-31 | $2.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-10 | $4.26K derived: sum of 2 quarters · filed 2016-05-10 | $6.45K 10-Q · filed 2016-05-10 | $8.65K derived: sum of 4 quarters · filed 2016-09-16 | |||||||||
| 2014-12-31 | $2.19K 10-Q · filed 2016-02-09 | $4.39K 10-Q · filed 2016-02-09 | $6.58K derived: sum of 3 quarters · filed 2016-09-16 | $8.77K derived: sum of 4 quarters · filed 2016-09-16 | |||||||||
| 2014-09-30 | $2.19K 10-Q · filed 2015-11-09 | $4.39K derived: sum of 2 quarters · filed 2016-09-16 | $6.58K derived: sum of 3 quarters · filed 2016-09-16 | $8.78K derived: sum of 4 quarters · filed 2016-09-16 | |||||||||
| 2014-06-30 | $2.19K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-16 | $4.39K derived: sum of 2 quarters · filed 2016-09-16 | $6.58K derived: sum of 3 quarters · filed 2016-09-16 | $8.78K 10-K · filed 2016-09-16 | |||||||||
| 2014-03-31 | $2.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-15 | $4.39K derived: sum of 2 quarters · filed 2015-05-15 | $6.58K 10-Q · filed 2015-05-15 | $8.78K derived: sum of 4 quarters · filed 2015-09-14 | $48.50K 10-Q · filed 2014-05-15 | ||||||||
| 2013-12-31 | $2.19K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2015-02-25 | $4.39K 10-Q · filed 2015-02-25 | $6.58K derived: sum of 3 quarters · filed 2015-09-14 | $8.77K derived: sum of 4 quarters · filed 2015-09-14 | $46.31K 10-Q · filed 2014-02-14 | ||||||||
| 2013-09-30 | $2.19K 10-Q/A · filed 2015-02-23 | $4.39K derived: sum of 2 quarters · filed 2015-09-14 | $6.58K derived: sum of 3 quarters · filed 2015-09-14 | $8.77K derived: sum of 4 quarters · filed 2015-09-14 | $44.11K 10-Q/A · filed 2013-11-18 | ||||||||
| 2013-06-30 | $2.19K derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-14 | $4.39K derived: sum of 2 quarters · filed 2015-09-14 | $6.58K derived: sum of 3 quarters · filed 2015-09-14 | $8.77K 10-K · filed 2015-09-14 | $41.92K 10-K/A · filed 2013-10-08 | ||||||||
| 2013-03-31 | $2.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-15 | $4.39K derived: sum of 2 quarters · filed 2014-05-15 | $6.58K 10-Q · filed 2014-05-15 | $8.78K derived: sum of 4 quarters · filed 2015-02-23 | $39.73K 10-Q/A · filed 2013-05-20 | ||||||||
| 2012-12-31 | $2.19K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2014-02-14 | $4.39K 10-Q · filed 2014-02-14 | $6.58K derived: sum of 3 quarters · filed 2015-02-23 | $13.16K derived: sum of 4 quarters · filed 2015-02-23 | $37.53K 10-Q/A · filed 2013-02-22 | ||||||||
| 2012-09-30 | $2.19K 10-Q/A · filed 2013-11-18 | $4.39K derived: sum of 2 quarters · filed 2015-02-23 | $10.97K derived: sum of 3 quarters · filed 2015-02-23 | $8.78K derived: sum of 4 quarters · filed 2015-02-23 | $35.34K 10-Q · filed 2012-11-19 | ||||||||
| 2012-06-30 | $2.19K derived: 10-K 12 month − 10-Q/A 9 month · filed 2015-02-23 | $8.78K derived: sum of 2 quarters · filed 2015-02-23 | $6.58K derived: sum of 3 quarters · filed 2015-02-23 | $8.78K 10-K · filed 2015-02-23 | $33.15K 10-K/A · filed 2012-10-26 | ||||||||
| 2012-03-31 | $6.58K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2013-05-20 | $4.39K derived: sum of 2 quarters · filed 2013-05-20 | $6.58K 10-Q/A · filed 2013-05-20 | ||||||||||
| 2011-12-31 | -$2.19K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2013-02-22 | $0.00 10-Q/A · filed 2013-02-22 | |||||||||||
| 2011-09-30 | $2.19K 10-Q · filed 2012-11-19 | ||||||||||||
| 2011-06-30 | $8.77K 10-K/A · filed 2012-10-26 | ||||||||||||
| 2010-06-30 | $7.50K 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |